Narrow Results Clear All
- Audiovisual 2
- Book/Report 1
- Legislation/Regulation 5
- Tools/Toolkit 3
- Web Resource 42
- Award 8
- Grant 3
- Meeting/Conference 1
- Press Release/Announcement
- Communication Improvement 7
- Culture of Safety 5
- Education and Training 11
- Error Reporting and Analysis 21
- Human Factors Engineering 18
- Legal and Policy Approaches 16
- Quality Improvement Strategies 28
- Specialization of Care 1
- Technologic Approaches 6
- Device-related Complications 16
- Diagnostic Errors 3
- Discontinuities, Gaps, and Hand-Off Problems 2
- Drug shortages 1
- Identification Errors 2
- Medical Complications 9
- Medication Errors/Preventable Adverse Drug Events 30
- MRI safety 4
- Nonsurgical Procedural Complications 4
- Surgical Complications 5
- Transfusion Complications 1
- Internal Medicine 15
- Surgery 3
- Nursing 2
- Pharmacy 24
- Health Care Executives and Administrators 51
Health Care Providers
- Nurses 9
- Pharmacists 12
- Physicians 12
Non-Health Care Professionals
- Media 3
- Patients 18
- Africa 1
- Asia 1
- Australia and New Zealand 1
- Central and South America 1
- Europe 1
- Canada 1
- United States of America 81
Search results for "North America"
- Press Release/Announcement
- North America
Bethesda, MD: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. May 21, 2018. PA-18-790; PA-18-791.
Chicago, IL: American Board of Medical Specialties; July 21, 2011.
This award will acknowledge individuals who have made significant contributions to patient safety and quality improvement efforts. The submission process for nominations is now closed.
MedWatch Safety Alert, FDA Drug Safety Communication. Silver Spring, MD: US Food and Drug Administration; June 13, 2011.
This notice raises awareness of a two look-alike/sound-alike drugs, one an antipsychotic medication and the other a dopamine agonist.
Oakbrook Terrace, IL: Joint Commission; May 17, 2011.
This announcement reveals the new National Patient Safety Goal for 2012, which aims to reduce catheter-acquired infections in hospitals.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; February 21, 2011.
This announcement reports the recall of several mislabeled products, including the commonly used anticoagulant warfarin.
Hydrocodone bitartrate and acetaminophen tablets, phenobarbital tablets by Qualitest: recall—incorrect package labeling.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; February 7, 2011.
This announcement reports the recall of two products that may have been mislabeled.
The Joint Commission. January 12, 2011.
The Eisenberg Award honors individuals and organizations who have made vital accomplishments in improving patient safety and quality. The 2010 honorees are John H. Eichhorn, MD; James L. Reinertsen, MD; Washington State Hospital Association, Seattle, Washington; and The Children's Hospital at Providence Newborn Intensive Care Unit, Anchorage, Alaska.
Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication use error—reports of accidental overdose.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; January 10, 2011.
This announcement reveals a labeling change to reduce the potential for misadministration of a pain medication.
Washington, DC: National Quality Forum; June 13, 2011.
This publication announces the 2011 National Quality Forum update of 2010 never events. The opportunity to provide open comment of the 29 serious reportable events, which includes 4 new events, has now passed.
Rockville, MD: US Food and Drug Administration; November 9, 2010.
This notice analyzes findings from a government initiative on CT scan injuries and provides recommendations to enhance safety and prevent such incidents.
Rockville, MD: Agency for Healthcare Research and Quality; November 3, 2010. Publication No. NOT-HS-11-002.
This announcement describes funding opportunities for research on health care–associated infections.
Federal Register. October 22, 2010;75:65359-65360.
This announcement discusses the Patient Safety Act, describes the role of Common Formats in collecting adverse event data through Patient Safety Organizations, and calls for feedback from the field to guide modifications.
New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; September 15, 2010.
This announcement describes revised dosing recommendations designed to prevent overdosing immunocompromised pediatric patients.
MedWatch Safety Alert, FDA Drug Safety Communication. Silver Spring, MD: US Food and Drug Administration; August 2, 2010.
This announcement reports on numerous errors in which an oral medication, nimodipine, was administered intravenously and describes how such errors occur.
US Food and Drug Administration. June 24–25, 2010; Marriott Residence Inn, Bethesda, MD.
This session kicks off an FDA initiative to redesign drug labeling in an effort to prevent medication errors and develop policies to support the changes. The opportunity to submit comments based on materials discussed at the session has passed.
National Alert Network for Serious Medication Errors. Bethesda, MD: American Society of Health-System Pharmacists and Institute for Safe Medication Practices; June 16, 2010.
This announcement describes potential dosing errors that may result from a shortage of pre-filled Epinephrine syringes.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; June 15, 2010.
This announcement cautions providers and parents about the potential for giving infants an overdose of vitamin D and describes how to avoid such errors.
MedWatch Safety Alert. Rockville, MD: US Food and Drug Administration; February 17, 2010.
This announcement alerts consumers and health care professionals to dangers associated with name confusion on a widely used over-the-counter medicine.
FDA Public Health Advisory [US Food and Drug Administration Web site]. January 19, 2010.
This FDA announcement alerts clinicians to reports of adverse events associated with benzocaine sprays and includes considerations for safer use of the sprays.
Horsham, PA. Institute for Safe Medication Practices.
These educational programs with the Institute for Safe Medication Practices (ISMP) are for clinicians who wish to expand their practical knowledge of medication error prevention. The application deadline for the 2019–2020 fellowships is June 30, 2019.